Cargando...

Strontium 89 for Palliation of Bone Metastases

At the University of Kansas Medical Center, systemic use of strontium 89 ((89)Sr), a betaemitting radioisotope, was evaluated in the treatment of metastatic carcinoma to bone for relief of bone pain. Eighty-five patients were treated with systemic (89)Sr in the dosage of 30 to 40 μCi/kg. All patient...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Reddy, Eashwer K., Robinson, Ralph G., Mansfield, Carl M.
Formato: Artigo
Lenguaje:Inglês
Publicado: 1986
Materias:
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC2571189/
https://ncbi.nlm.nih.gov/pubmed/2419578
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!